However, data obtained from multiple experiments performed with HIV-1ADA established that the anti-Trx mAb was more efficient in reducing RT values and delaying the time of peak RT activity during infection (Figure3D,E and data not shown), suggesting that Trx may play a greater role in disulfide bond rearrangement in HIV-1 R5 isolates. The gene discussed is TXN; the disease is infection.